we describe 2 patients in whom a sustained remission of longstanding rheumatoid arthritis occurred with treatment for acute myelogenous leukemia ( cytosine arabinoside , daunorubicin , and m-amsa ) , even though both illnesses had been refractory to therapy with standard disease-modifying agents .
C0023467
acute myelogenous leukemia
C0011015
daunorubicin